Conference abstract · 18 Mar 2019
Conference abstract
LinkSeq genotyping: Fast, easy molecular antigen typing
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Statement of the Problem: Blood typing using serology can provide an inaccurate answer if a patient is recently transfused, taking oncology therapeutics like Darzalex, or has weak or partial antigens. Antisera are not always available for rare antigens. Chronically transfused patients can avoid alloimmunization by receiving antigen-negative blood units, but building a complete patient or donor antigen profile using serology is labor-intensive and can take days. Blood genotyping using traditional methods such as SSP and SSO overcome the limitations of serotyping, but require long, labor-intensive workflows and limited resolution. Blood genotyping using Sanger or NGS sequencing technology have high resolution, but are even more time and labor consuming, expensive and require interpretation by subject matter experts. Solution: Thermo Fisher Scientific’s Link Seq real-time PCR technology accelerates turn-around times reducing laboratory costs and provides medium to high resolution results that can be interpreted by clinicians and interrogated by genotyping experts. LinkSeq utilizes allele specific PCR reactions to identify important variants and its SureTyper™ software analyzes reaction results to automatically determine the genotype and predict a phenotype. LinkSeq was developed over 10 years ago for genotyping the complex Human Leukocyte Antigen (HLA) system and can be performed on the same equipment as real-time PCR based HLA typing assays, which are widely used for deceased donor typing. Conclusion & Significance: LinkSeq blood genotyping solutions overcome the major challenges of molecular typing by providing a robust, automated approach that increases laboratory productivity and reduces turn-around time. With less than 10 minutes of hands on set-up, no further operator intervention with reagents and SureTyper software by fully automating all analysis, LinkSeq delivers genotyping and predicted phenotyping results in approximately 90 minutes. Recent Publications 1. Keller M A (2015) The role of red cell genotyping in transfusion medicine. Immunohematology 31(2):49-52. 2. Flegel W A, Gottschall J and Denomme G (2015) Implementing mass-scale genotyping at a blood center. Transfusion 55(11):2610-5. 3. Kacker S, Vassallo R, Keller M A, Westhoff C M, Frick K D, Sandler S G, Tobian A A (2015) Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype. Transfusion 55(9):2095-103. 4. Sandler S G, Flegel W A, Westhoff C M, Denomme G A, Delaney M, Keller M A, Johnson S T, Katz L, Queenan J T, Vassallo R R and Simon C D (2015) It’s time to phase in RHD genotyping for patients with a serologic weak D phenotype. College of American Pathologists Transfusion Medicine Resource Committee Work Group. Transfusion 55(3):680-9. 5. Silvy M, Tournamille C, Babinet J, Pakdaman S, Cohen S, Chiaroni J, Galacteros F, Bierling P, Bailly P and Noizat-Pirenne F (2014) Red blood cell immunization in sickle cell disease: evidence of a large responder group and a low rate of anti-Rh linked to partial Rh phenotype. Haematologica 99(7):e115-e117.
Subjects
HaematologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 29 Sep 2023
Blood Group Antigen Genotyping in Immunohematology: Current Status and Future Prospects
Case report · 17 Mar 2023
Genotyping of Blood Donors for Timely Procurement of Rare Antigen-Negative Blood: A Case Story of Acute HTR and Anti-Coa
Conference abstract · 21 Sep 2015
Identification, molecular cloning, and preparation of antigenic hepatitis C virus genotype 4a recombinant NS2 protein
Research article · Dec 2018
The Effects of Apple Vinegar on Fasting Blood Sugar (FBS) and Glycosylated Hemoglobin in Patients with Type 2 Diabetes
More from this journal
The newest in Journal of Blood Disorders & Transfusion.
Article · 8 Jun 2026
Analysis of Motivations and Barriers to Voluntary Blood Donation in the Thessalian Population: Findings from a Quantitative Study
Article · 30 Apr 2026
Cellular Neighbourhoods of Blood Formation: Understanding the Hematopoietic Microenvironment
Article · 30 Apr 2026
Erythrocyte Membrane Disorders: Structural Defects and Their Impact on Red Blood Cell Survival
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Blood Disorders & Transfusion
- SubjectHaematology
- BylineArticles whose byline prints “Matthew Frome”
